Home Daily Stock Opinions and Ratings Veru (VERU-Q)

Trending stocks today

Brookfield Corp NextEra Energy Black Diamond Group Cheniere Energy Inc PDD Holdings Astera Labs Marvell Technology Group Broadcom Invesco QQQ Trust Series 1 Coca-Cola Company Loews Corp Softchoice Everest Group, Ltd. Parkland Fuel Corp Canadian Tire Corporation Ltd. (A) BCE Inc. Alimentation Couche-Tard BMO S&P/TSX Oil & Gas ETF iShares Silver ETF Sprott Uranium Physical Trust

Veru (VERU-Q)

NEW AI Investor Insights
18 watching

NASDAQ:VERU

1.27
0.06 (4.96%) 1d
Apr 26, 2024, 7:59 pm
0
DON'T BUY

Veru(VERU-Q)

17/10/2022
Veru
64% of this company's share floated is shorted, so the market is betting against it.
biotechnology / pharmaceutical
Jim Cramer - Mad Money
$11.470
Unknown
UnlockRating
BUY

Veru(VERU-Q)

10/01/2022
Veru
Their breast cancer treatment just got fast-tracked by the FDA today. And yet, shares fell $5. This makes no sense. This should have risen.
biotechnology / pharmaceutical
Jim Cramer - Mad Money
$5.340
Unknown
UnlockRating
BUY

Veru(VERU-Q)

10/11/2021
Veru
Their prostate cancer drug is real. For $8/share, you're in good shape.
biotechnology / pharmaceutical
Jim Cramer - Mad Money
$8.370
Unknown
UnlockRating
BUY

Veru(VERU-Q)

26/04/2021
Veru
It's come down a lot--too much, but boasts some fine drugs. A crazy trading stock, but he believes in it.
biotechnology / pharmaceutical
Jim Cramer - Mad Money
$9.430
Unknown
UnlockRating
BUY

Veru(VERU-Q)

08/02/2021
Veru
It soared 28% today off great Covid drug data. They've been developing treatments for breast and prostate cancers. A few months ago, the stock tripled on stage 2 clinical trial data for their breast cancer therapy. Earlier this year, they started studying one of their cancer drugs to treat acute respiratory distress caused by severe Covid. This drug showed an 82% in deaths. Phase 3 results will likely come in Q4.
biotechnology / pharmaceutical
Jim Cramer - Mad Money
$13.920
Unknown
UnlockRating
BUY

Veru(VERU-Q)

14/12/2020
Veru
It was the biggest gainer in biotech today, this little-known name which soared 52.56% today. This drugmaker focuses on oncology and urology. It's tripled in the past week. They just produced promising phase 2 clinical trial data for their drugs treating breast cancer, and more positive data for prostate cancer. He doesn't chase stocks after a big run, but positive trial data spells a promising stock.
biotechnology / pharmaceutical
Jim Cramer - Mad Money
$9.695
Unknown
UnlockRating
Showing 1 to 6 of 6 entries
  • «
  • ‹
  • 1
  • ›
  • »

Veru(VERU-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Veru is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Veru(VERU-Q) Frequently Asked Questions

What is Veru stock symbol?

Veru is a American stock, trading under the symbol VERU-Q on the NASDAQ (VERU). It is usually referred to as NASDAQ:VERU or VERU-Q

Is Veru a buy or a sell?

In the last year, there was no coverage of Veru published on Stockchase.

Is Veru a good investment or a top pick?

Veru was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Veru.

Why is Veru stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Veru worth watching?

0 stock analysts on Stockchase covered Veru In the last year. It is a trending stock that is worth watching.

What is Veru stock price?

On 2024-04-26, Veru (VERU-Q) stock closed at a price of $1.27.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Get Access To Watchlist

Latest Buy Signals

GOOG-QAlphabet Inc
Alphabet Inc
$173.62
15.67 (8.28%)
TEAM-QAtlassian
Atlassian
$179.62
-18.79 (-11.68%)
ROKU-QRoku Inc
Roku Inc
$56.33
-6.48 (-13.00%)
SOXX-QiShares PHLX Semiconductor ETF.
iShares PHLX Semiconductor ETF.
$216.89
4.48 (2.02%)
CYH-TiShares Global Advantage Dividend E.T.F.
iShares Global Advantage Dividend E.T.F.
$20.35
0.03 (0.15%)
Advertising

Today's Top Picks

U.UN-TSprott Uranium Physical Trust
Sprott Uranium Physical Trust
$28.95
0.75 (2.53%)
SLV-NiShares Silver ETF
iShares Silver ETF
$24.89
-0.17 (-0.69%)
ZEO-TBMO S&P/TSX Oil & Gas ETF
BMO S&P/TSX Oil & Gas ETF
$72.77
0.02 (0.03%)
ATD-TAlimentation Couche-Tard
Alimentation Couche-Tard
$77.75
0.37 (0.47%)
BCE-TBCE Inc.
BCE Inc.
$44.59
-0.33 (-0.75%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

CCO-TCameco Corporation
Cameco Corporation
$67.38
0.22 (0.33%)
DOL-TDollarama Inc.
Dollarama Inc.
$115.62
-1.38 (-1.21%)
NSC-NNorfolk Southern
Norfolk Southern
$239.94
-0.89 (-0.37%)
ALAB-QAstera Labs
Astera Labs
$84.95
13.36 (13.59%)
UNH-NUnitedHealth Group Inc
UnitedHealth Group Inc
$495.35
1.49 (0.30%)

Most Recent Experts

Philbrick

Mike Philbrick

ReSolve Asset Management

Stockchase

Stockchase Insights

5i Research

Panic-Proof (Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Buzzing

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Gill

Robert Gill

Goodreid Investment Council

Advertising
Advertising
logoTop pickslogoStockslogoRecentlogoWatchlist
© Stockchase Inc.